<?xml version="1.0" encoding="UTF-8"?>
<results title="testTrace">
 <result pre="infections. Several NK cell therapeutic options already exist in the" exact="treatment" post="of tumor and other viral diseases and could be"/>
 <result pre="injury. Several NK cellâ€&quot;based therapeutics currently in development against COVID-19" exact="infection" post="employ different strategies, including inducing NK cell activation, inhibiting"/>
 <result pre="MERS, has helped piece together the clinical course of COVID-19" exact="infection" post="[5,6], which Mason and colleagues [7] describe as 3"/>
 <result pre="incubation period of 5.1 days, the first stage of COVID-19" exact="infection" post="is characterized by local viral replication and shedding in"/>
 <result pre="mice models were shown to be only semipermissive to SARS-CoV-1" exact="infection" post="since murine ACE2 binds less efficiently than human ACE2"/>
 <result pre="adults [30,32]. Neutralizing antibody development and cellular immunity after primary" exact="infection" post="in rhesus macaques was found to protect against reinfection"/>
 <result pre="subsets in the periphery. NK cells at sites of SARS-CoV-2" exact="infection" post="Lung NK cells account for approximately 10% to 20%"/>
 <result pre="as nausea, vomiting, and diarrhea, are also associated with SARS-CoV-2" exact="infection" post="with viral shedding in fecal samples [60, 61]. NK"/>
 <result pre="inflammation in the brain [67]. The fatal outcome of brain" exact="infection" post="in this model could be attributed to any of"/>
 <result pre="could be attributed to any of these several mechanisms: neuronal" exact="infection" post="and dropout, infection of the cardiorespiratory center in the"/>
 <result pre="to any of these several mechanisms: neuronal infection and dropout," exact="infection" post="of the cardiorespiratory center in the medulla, and cytokine"/>
 <result pre="cells into the brain and was critical in controlling MHV" exact="infection" post="before T cell responses were activated in the brain"/>
 <result pre="in general early immune responses at the primary site of" exact="infection" post="and the lungs in coronaviral infections in both humans"/>
 <result pre="human placental CD34+ cells and is being tested for the" exact="treatment" post="acute myeloid leukemia and multiple myeloma. Recently, the Food"/>
 <result pre="Recently, the Food and Drug Administration (FDA) has approved the" exact="testing" post="of CYNK-001 as a potential universal NK therapy for"/>
 <result pre="therefore, could prove to be a low risk, more rigorous" exact="testing" post="and experimental data is essential to understand the true"/>
 <result pre="NK cell responses would be more effective early in the" exact="infection" post="and would prevent progression of the disease. Immunomodulation of"/>
 <result pre="on myeloid cells, neutralizing antibodies, and T cells in SARS-CoV-2" exact="infection" post="while an important antiviral defense system, the NK cells,"/>
 <result pre="10.1016/S0140-6736(20)30251-832007145 5LiX, GengM, PengY, MengL, LuS. Molecular immune pathogenesis and" exact="diagnosis" post="of COVID-19. J Pharm Anal. 2020 Epub 2020/04/14. 10.1016/j.jpha.2020.03.00132282863"/>
 <result pre="10.1038/s41586-020-2312-y .32380511 24McCrayPBJr., Pewe, Wohlford-LenaneC, HickeyM, ManzelL, ShiL, et al.Lethal" exact="infection" post="of K18-hACE2 mice infected with severe acute respiratory syndrome"/>
 <result pre="2020/04/19. 10.1126/science.abb731432303590 31ChandrashekarA, LiuJ, MartinotAJ, McMahanK, MercadoNB, PeterL, et al.SARS-CoV-2" exact="infection" post="protects against rechallenge in rhesus macaques. Science. 2020 Epub"/>
 <result pre="JuangSW, KaneKP. NK cells exacerbate the pathology of influenza virus" exact="infection" post="in mice. Eur J Immunol. 2013;43(4):929â€&quot;38. Epub 2013/02/26. 10.1002/eji.201242620"/>
 <result pre="al.Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV)" exact="infection" post="in senescent BALB/c mice: CD4+ T cells are important"/>
 <result pre="of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary" exact="infection" post="of mice. J Immunol. 2004;173(6):4030â€&quot;9. Epub 2004/09/10. 10.4049/jimmunol.173.6.4030 .15356152"/>
 <result pre="67NetlandJ, MeyerholzDK, MooreS, CassellM, PerlmanS. Severe acute respiratory syndrome coronavirus" exact="infection" post="causes neuronal death in the absence of encephalitis in"/>
 <result pre="HurstKR, HardisonJL, ManningJE, et al.CXC chemokine ligand 10 controls viral" exact="infection" post="in the central nervous system: evidence for a role"/>
 <result pre="immunity in COVID-19 patients mediated by NKG2A receptors, and potential" exact="treatment" post="using Monalizumab, Cholroquine, and antiviral agents. Med Hypotheses. 2020;140:109777"/>
 <result pre="al.Triple combination of interferon beta-1b lopinavir-ritonavir, and ribavirin in the" exact="treatment" post="of patients admitted to hospital with COVID-19: an open-label,"/>
</results>
